Radiopharm Theranostics Limited (AU:RAD) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Radiopharm Theranostics Limited has successfully listed its American Depositary Shares on the Nasdaq Capital Market under the ticker symbol ‘RADX’, marking a significant strategic milestone. This secondary listing aims to enhance the company’s visibility among U.S. and international investors without any associated capital raising. Existing U.S. shareholders currently hold 21% of Radiopharm, and the company continues its focus on developing innovative radiopharmaceuticals for oncology.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.